on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Investment Update on Mural Oncology
The Vanguard Group, Inc., a significant investor in Mural Oncology plc, reported its investment position as part of the Irish Takeover Panel regulations. The disclosure, dated August 14, 2025, reflects the company's interests in the securities of Mural Oncology, highlighting their importance as a stakeholder.
The Vanguard Group holds 771,891 ordinary shares of Mural Oncology, representing a 4.47% stake. This disclosure ensures transparency in financial engagements concerning potential takeover dealings. The transactions reported included a purchase and sale of shares at a price of 1.79 USD per unit.
No additional cash-settled or stock-settled derivative positions have been disclosed. Furthermore, the company reported no indemnity, option arrangements, or agreements impacting its position regarding Mural Oncology shares. This disclosure underscores the absence of any hidden commitments or intent to alter voting rights related to their current shareholding.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news